Improvement in fasting blood glucose levels, blood lipid levels, hepatic steatosis, and scapular brown fat whitening;Reduction of Aβ 40–42 levels in the cerebral cortex of APP/PS1 mice and improved cognitive functions. This evidence concerns the gene APP and fatty liver disease.